News

Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
Receipt of EU MDR CE mark may not be a magic potion, but Elixir Medical Corp. is certainly feeling a boost from the regulatory nod for its mechanical Lithix hertz contact intravascular lithotripsy ...
Zimmer Biomet (NYSE:ZBH) announced Tuesday that the EU regulators granted CE Mark certification for the company’s RibFix Advantage Fixation System, designed as a less invasive approach to rib ...
Cerus Corporation (NASDAQ:CERS) said on Wednesday that the company received CE mark approval for its illumination device, the INT200, to commercialize in the European Union. This device is part of ...
Beam Global announced that its products, including EV ARC™, BeamBike™, BeamWell™, and BeamPatrol™, have received the CE mark, which signifies compliance with European Union health ...
(RTTNews) - Medtronic plc (MDT), Monday said it received CE Mark approval for its BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier in the European Union and ...
"The CE Mark approval of the Auryon System is a significant milestone that underscores our commitment to bringing safe and effective solutions to healthcare professionals treating peripheral ...
Vitestro is the first company ever to achieve CE marking for an autonomous blood drawing device. The CE marking underscores the safety, efficacy, and quality of Vitestro's innovative technology ...
LATHAM, N.Y., May 21, 2024--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s ...
[Image courtesy of Abbott] Abbott (NYSE:ABT) + announced today that it received CE mark approval for its Assert ... Physicians can insert the small, thin Assert-IQ device under the skin of the ...
CE Mark follows recent approval of the VARIPULSE™ Platform in Japan. IRVINE, Calif., Feb. 29, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and ...